4 results
Efficacy and safety during 24 treatment weeks.
Primary: To demonstrate non-inferiority of RELVAR 100/25 once-daily to SERETIDE 250/50 twice-daily in adult and adolescent subjects 12 years of age and older with persistent asthma,adequately controlled on twice-daily ICS/LABA. Secondary: Adverseā¦
Feasibility is assessed after every VR-EMDR session and after treatment completion. PTSD symptoms, quality of life and self-empowerment are assessed before and after treatment.
Identifying the fixation and migration patterns of the G7 BiSpherical acetabular system combined with the GTS stem (Zimmer Biomet) prosthesis in vivo, using model based roentgen radiostereophotogrammetric (mRSA) analysis over a period of 10 years.